Overview and Scope
Male hypogonadism is a disease in which the body produces insufficient amounts of the hormone testosterone. Testosterone is the primary male sex hormone and is essential for the development and growth of men throughout puberty.
Sizing and Forecast
The male hypogonadism market size has grown strongly in recent years. It will grow from $3.55 billion in 2023 to $3.8 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, awareness and diagnosis, lifestyle factors, chronic illnesses, treatment seeking behavior..
The male hypogonadism market size is expected to see strong growth in the next few years. It will grow to $4.77 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to rising awareness, prevalence of lifestyle-related conditions, innovations in therapies, emphasis on men’s health, telemedicine and healthcare accessibility.. Major trends in the forecast period include attention to psychological and sexual health, exploration of nutraceuticals and lifestyle interventions, market expansion in emerging economies, collaborative research initiatives, focus on long-term safety and monitoring..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report
Segmentation & Regional Insights
The male hypogonadism market covered in this report is segmented –
1) By Type: Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, Other Types
2) By Drug Delivery: Topical Gels, Injectables, Transdermal Patches, Other Drug Deliveries
3) By Therapy: Testosterone Therapy, Gonadotropin-Releasing Hormone Therapy
North America was the largest region in the male hypogonadism market in 2023. Asia-Pacific is expected to be the fastest-growing region in the male hypogonadism market report during the forecast period. The regions covered in the male hypogonadism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9969&type=smp
Major Driver Impacting Market Growth
The increase in infertility rates is expected to propel the growth of the male hypogonadism market going forward. Infertility refers to a condition affecting the male or female reproductive system that is characterized by the inability to conceive after 12 months or longer of frequent, unprotected sexual activity. Male hypogonadism, which can lead to decreased sperm production and infertility, is one of the potential causes of male infertility. As a result, the increasing prevalence of male infertility is expected to drive the growth of the male hypogonadism market. For instance, in March 2023, according to the National Institutes of Health (NIH), a US-based Department of Health and Human Services in North America, the estimated male infertility rate is between 4.5% – 6%, while it’s 9% in Australia and could be as high as 8% to 12% in Eastern Europe. Also, according to a 2021 study published by the Libyan Journal of Medical Sciences, around 70% of infertility is attributed to male factors in Libya. Therefore, an increase in the infertility rate is driving the growth of the male hypogonadism market.
Key Industry Players
Major companies operating in the male hypogonadism market are focusing on developing innovative products such as digital-forward platforms to engage patients through telemedicine, offer educational resources, and streamline access to treatments, revolutionizing care for male hypogonadism while enhancing patient support and therapy accessibility. A digital health platform exclusively for men, accessible through subscription, provides various virtual health services and resources. For instance, in October 2022, Base Healthcare, a US-based men’s virtual health platform, launched a subscription-based men’s virtual health platform, prioritizing fundamental health and hormone enhancement through oral testosterone treatment. This digital platform provides men with convenient access to adequate testosterone therapy (ATT), certified medical professionals, and personalized health guidance.
The male hypogonadism market report table of contents includes:
1. Executive Summary
2. Male Hypogonadism Market Characteristics
3. Male Hypogonadism Market Trends And Strategies
4. Male Hypogonadism Market – Macro Economic Scenario
5. Global Male Hypogonadism Market Size and Growth
…
31. Global Male Hypogonadism Market Competitive Benchmarking
32. Global Male Hypogonadism Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Male Hypogonadism Market
34.Male Hypogonadism Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
